MedTrace Logo

Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial

NCT00256152 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 2580

Last updated 2019-02-04

No results posted yet for this study

Summary

In patients with a standard indication for pacing and no previous history of AF, detection of Atrial High Rate Episodes predicts an increased risk of stroke and systemic embolism.

Overdrive atrial pacing with the AF Suppression algorithm will reduce the risk of symptomatic AF in patients with standard indication for pacing and no previous history of AF.

Conditions

Interventions

DEVICE

AF Suppression Pacing Algorithm

Sponsors & Collaborators

  • Population Health Research Institute

    collaborator OTHER

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Stuart Connolly, MD · McMaster University

  • Stephan Hohnloser, MD · Goethe University

  • Carlos Morillo, MD · McMaster University

  • Jeff Healey, MD · McMaster University

  • Carsten Israel, MD · Goethe University

  • Michael Gold, MD · Medical University of South Carolina

  • Chu-Pak Lau, MD · The University of Hong Kong

  • Alessandro Capucci, MD · Ospedale Clinic, Piacenza Italy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00256152 on ClinicalTrials.gov